Detalhe da pesquisa
1.
STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Blood
; 142(3): 274-289, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989489
2.
ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356460
3.
In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts.
Pediatr Blood Cancer
; 70(8): e30398, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140091
4.
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts.
Pediatr Blood Cancer
; : e30503, 2023 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339930
5.
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
Br J Cancer
; 125(1): 55-64, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837299
6.
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
Int J Cancer
; 146(7): 1902-1916, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325323
7.
Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.
Br J Cancer
; 122(12): 1769-1781, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242100
8.
Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
Br J Cancer
; 123(5): 742-751, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32536690
9.
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(4): e28133, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876116
10.
Anesthetic concerns for pediatric patients in the era of COVID-19.
Paediatr Anaesth
; 30(7): 737-742, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438527
11.
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts.
Pediatr Blood Cancer
; 66(8): e27765, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012549
12.
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
Br J Cancer
; 118(7): 1000-1004, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531323
13.
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia.
Blood
; 128(10): 1382-95, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27343252
14.
Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Blood
; 125(2): 273-83, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336632
15.
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia.
Blood
; 126(10): 1193-202, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116659
16.
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Blood
; 125(11): 1759-67, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645356
17.
Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 64(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27786412
18.
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.
Pediatr Blood Cancer
; 64(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650817
19.
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 63(3): 443-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26797892
20.
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 63(10): 1744-52, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238606